Can lactate be cleared by dialysis (Dialysis)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Lactate Be Cleared by Dialysis?

Yes, lactate can be cleared by dialysis, but the contribution of dialysis to total lactate clearance is minimal (typically <3% of total body lactate clearance) and should not be relied upon as a primary mechanism for treating hyperlactatemia. 1

Quantitative Evidence on Lactate Clearance by Dialysis

Continuous Renal Replacement Therapy (CRRT)

  • Filter lactate clearance during continuous venovenous hemofiltration with dialysis (CVVHD) is approximately 24 mL/min (range 7-36 mL/min), which represents less than 3% of total body lactate clearance of approximately 1379 mL/min in critically ill patients. 1
  • Peritoneal dialysis provides even lower lactate clearance at approximately 9 mL/min, though it can remove between 88-352 mEq of total lactate during a dialysis session. 2

Clinical Implications

  • Because dialytic lactate clearance is negligible compared to endogenous metabolism, lactate levels remain a reliable marker of tissue oxygenation and shock even in patients receiving renal replacement therapy. 1
  • The body's endogenous lactate metabolism capacity far exceeds what any dialysis modality can achieve, meaning dialysis cannot mask lactate overproduction from tissue hypoperfusion. 1

Critical Guideline Recommendations on Lactate-Buffered vs. Bicarbonate-Buffered Dialysate

Strong Recommendations Against Lactate-Based Solutions in Specific Populations

The KDIGO guidelines strongly recommend (1B) using bicarbonate rather than lactate as a buffer in dialysate and replacement fluid for patients with AKI and circulatory shock. 3, 4

For patients with AKI and liver failure and/or lactic acidemia, bicarbonate is suggested (2B) over lactate-buffered solutions. 3, 5, 4

Rationale for Avoiding Lactate-Buffered Solutions

  • In patients with liver failure or lactic acidosis, lactate-containing dialysis solutions may worsen acidosis rather than improve it, as the liver cannot efficiently convert the exogenous lactate load to bicarbonate. 5
  • Lactate-buffered CRRT can cause hyperlactatemia in all patients, with less than 40% of acute renal failure patients showing the expected improvement in acid-base status (increased bicarbonate, reduced hydrogen ions). 6
  • A positive correlation exists between increased arterial lactate and hydrogen ion concentrations (r=0.52, p<0.01) when using lactate-buffered solutions, potentially worsening acidosis. 6

Comparative Effectiveness: Lactate-Free vs. Lactate-Buffered Dialysate

Acid-Base Control

  • Lactate-free (bicarbonate-based) dialysate provides more rapid control of acidosis than lactate-buffered dialysate in patients with multi-organ failure. 7
  • Bicarbonate-based solutions require less total buffer administration compared to lactate-buffered solutions. 7

Hemodynamic Stability

  • Mean arterial pressure rises during lactate-free dialysis with decreased inotrope requirements, while it falls during lactate-buffered dialysis with increased inotrope needs. 7
  • This hemodynamic advantage occurs regardless of whether patients have liver dysfunction. 7

Lactate Accumulation

  • While lactate accumulation is generally slight with both approaches over 24 hours in patients with multi-organ failure, it is higher during lactate-buffered CVVHD. 7
  • Lactate accumulation in critically ill patients near their threshold for lactate utilization may further depress cardiac function and peripheral lactate metabolism. 6

Clinical Pitfalls and Caveats

Common Misconception

  • Do not rely on dialysis to "clear" elevated lactate levels in shock or sepsis—the primary treatment must address the underlying cause of lactate production (tissue hypoperfusion, sepsis, etc.). 3, 1

Monitoring Requirements

  • When using lactate-buffered solutions in critically ill patients, arterial pH must be monitored so that bicarbonate solutions can be substituted if acid-base status progressively worsens. 6
  • Lactate levels remain valid for monitoring tissue perfusion and shock severity even during dialysis. 1

Special Populations Requiring Bicarbonate-Based Solutions

  • Patients with circulatory shock (strong recommendation) 3
  • Patients with liver failure or pre-existing lactic acidemia (suggested recommendation) 3, 5
  • Patients with acute kidney injury requiring CRRT 3, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.